Altogether, these findings suggest that Antho 50 induces a combined effect to kill CLL cells through caspase 3 activation and inhibition of UHRF1-regulated expression of several proteins involved in the repression of tumor suppressor genes. This evidence concerns the gene UHRF1 and B-cell chronic lymphocytic leukemia.